IgA nephropathy (IgAN) is a leading cause of CKD and renal failure. Recent international
collaborative efforts have led to important discoveries that have improved our understanding …

Abstract Globally, IgA nephropathy (IgAN) is the most common primary glomerulonephritis
that can progress to renal failure. The exact pathogenesis of IgAN is not well defined, but …

Glomerular disease, be it primary or secondary, occurring in the setting of systemic
autoimmune diseases, infections, drugs, or malignancy, affects individuals of all ages. In …

The Kidney Disease: Improving Global Outcomes (KDIGO) initiative organized a
Controversies Conference on glomerular diseases in November 2017. The conference …

Most glomerulonephritides, even the more common types, are rare diseases. They are
nevertheless important since they frequently affect young people, often cannot be cured, and …

IgA nephropathy frequently leads to progressive CKD. Although interest surrounds use of
immunosuppressive agents added to standard therapy, several recent studies have …

Background Observational studies suggest that patients with immunoglobulin A
nephropathy (IgAN) with active proliferative lesions show a good response to …

Since it was first described in 1968, immunoglobulin A nephropathy (IgAN) is understood to
be the most common form of glomerulonephritis worldwide. The diagnosis of IgAN depends …

Immunoglobulin A nephropathy (IgAN) is one of the commonest global patterns of primary
glomerulonephritis and remains a leading cause of chronic kidney disease and end‐stage …

Immunoglobulin A nephropathy (IgAN) is the most common primary form of glomerular
disease worldwide and carries a high lifetime risk of kidney failure. The underlying …